The clinical consequence and probable molecular processes of CDKN2A in various malignancies were also explored in this work, revealing the significant function of CDKN2A expression in pan-cancer and offering a fresh and potentially effective therapeutic target. This evidence concerns the gene CDKN2A and cancer.